Merck's announcement that former CDC director Julie Gerberding (CDC director 2002-2009) would become president of Merck Vaccines, then a roughly $5 billion global vaccine business — the canonical revolving-door example.
named president of Merck Vaccines, effective January 25, 2010
Merck's announcement that former CDC director Julie Gerberding (CDC director 2002-2009) would become president of Merck Vaccines, then a roughly $5 billion global vaccine business — the canonical revolving-door example. Company news reported via trade press; Merck's own contemporaneous release underlies the announcement.